Profiling bacteria in the lungs of patients with severe influenza versus COVID-19 with or without Aspergillosis

dc.contributor.authorFeys, Simonpor
dc.contributor.authorCardinali-Benigni, Martinapor
dc.contributor.authorLauwers, Hanne Moonpor
dc.contributor.authorJacobs, Catopor
dc.contributor.authorStevaert, Anneliespor
dc.contributor.authorGonçalves, Samuel Mpor
dc.contributor.authorCunha, Cristinapor
dc.contributor.authorDebaveye, Yvespor
dc.contributor.authorHermans, Greetpor
dc.contributor.authorHeylen, Jannespor
dc.contributor.authorHumblet-Baron, Stephaniepor
dc.contributor.authorLagrou, Katrienpor
dc.contributor.authorMaessen, Lennpor
dc.contributor.authorMeersseman, Philippepor
dc.contributor.authorPeetermans, Marijkepor
dc.contributor.authorRedondo-Rios, Alvaropor
dc.contributor.authorSeldeslachts, Laurapor
dc.contributor.authorStarick, Marick Rpor
dc.contributor.authorThevissen, Karinpor
dc.contributor.authorVande Velde, Greetjepor
dc.contributor.authorVandenbriele, Christophepor
dc.contributor.authorVanderbeke, Lorepor
dc.contributor.authorWilmer, Alexanderpor
dc.contributor.authorNaesens, Lievepor
dc.contributor.authorvan de Veerdonk, Frank Lpor
dc.contributor.authorVan Weyenbergh, Johanpor
dc.contributor.authorGabaldón, Tonipor
dc.contributor.authorWauters, Joostpor
dc.contributor.authorCarvalho, Agostinhopor
dc.date.accessioned2025-07-17T08:43:15Z
dc.date.available2025-07-17T08:43:15Z
dc.date.issued2024-11-15
dc.descriptionData availability: All sequences were deposited in the NCBI Sequence Read Archive under the BioProject ID PRJNA1045644. Gene expression data used in this manuscript are available in the appendix of the publication in which these data were featured originally (Reference 12). The analytical codes for the 16S rRNA gene sequencing analyses are available under https://github.com/Gabaldonlab/lung_microbiome_16S.por
dc.description.abstractRationale: The influence of the lung bacterial microbiome, including potential pathogens, in patients with influenza-associated pulmonary aspergillosis (IAPA) or coronavirus disease (COVID-19)-associated pulmonary aspergillosis (CAPA) has yet to be explored. Objectives: To explore the composition of the lung bacterial microbiome and its association with viral and fungal infection, immunity, and outcome in severe influenza versus COVID-19 with or without aspergillosis. Methods: We performed a retrospective study in mechanically ventilated patients with influenza and COVID-19 with or without invasive aspergillosis in whom BAL for bacterial culture (with or without PCR) was obtained within 2 weeks after ICU admission. In addition, 16S rRNA gene sequencing data and viral and bacterial load of BAL samples from a subset of these patients, and of patients requiring noninvasive ventilation, were analyzed. We integrated 16S rRNA gene sequencing data with existing immune parameter datasets. Measurements and Main Results: Potential bacterial pathogens were detected in 20% (28/142) of patients with influenza and 37% (104/281) of patients with COVID-19, whereas aspergillosis was detected in 38% (54/142) of patients with influenza and 31% (86/281) of patients with COVID-19. A significant association between bacterial pathogens in BAL fluid and 90-day mortality was found only in patients with influenza, particularly patients with IAPA. Patients with COVID-19, but not patients with influenza, showed increased proinflammatory pulmonary cytokine responses to bacterial pathogens. Conclusions: Aspergillosis is more frequently detected in the lungs of patients with severe influenza than bacterial pathogens. Detection of bacterial pathogens associates with worse outcome in patients with influenza, particularly in those with IAPA, but not in patients with COVID-19. The immunological dynamics of tripartite viral-fungal-bacterial interactions deserve further investigation.por
dc.description.sponsorshipSupported by Fonds Wetenschappelijk Onderzoek grant G053121N (S.H.-B. and J.W.) and grants G0A0621N and G065421N (J.V.W.) and Ph.D. grants 11M6922N and 11M6924N (S.F.), 11PBR24N (J.H.), 1186121N and 1186123N (L.S.), and 11E9819N (L.V.); the Universitaire Ziekenhuizen Leuven, KU Leuven “Coronafonds” (J.W.); the Fundacão para a Ciência e a Tecnologia grants UIDB/50026/2020, UIDP/50026/2020, and PTDC/MED-OUT/1112/2021 (https://doi.org/10.54499/PTDC/MED-OUT/1112/2021) (A.C.), and 2022.06674.PTDC (https://doi.org/10. 54499/2022.06674.PTDC) and CEECIND/04058/2018 (https://doi.org/10.54499/CEECIND/04058/2018/CP1581/CT0015) (C.C.); the “la Caixa” Foundation under the agreement LCF/PR/HR22/52420003 (MICROFUN) (C.C.); and the European Union’s Horizon 2020 Framework Programme grant agreement number 847507 (Host-Directed Medicine in Invasive Fungal Infections) (F.L.v.d.V., A.C., and J.W.). For this research, the Toni Gabaldon group acknowledges support from the Ministerio de Ciencia e Innovacion for grants PID2021-126067NB-I00, CPP2021-008552, PCI2022-135066-2, and PDC2022-133266-I00, cofounded by ERDF “A way of making Europe”; the Agencia de Gestió d’Ajuts Universitaris i de Recerca grant SGR01551; European Union’s Horizon 2020 research and innovation programme grant ERC-2016-724173; Gordon and Betty Moore Foundation grant GBMF9742; “La Caixa” foundation grant LCF/PR/HR21/00737; and Instituto de Salud Carlos III grants IMP/00019 and CIBERINFEC CB21/13/00061-ISCIII-SGEFI/ERDF.por
dc.distributioninternationalpor
dc.identifier.citationFeys, S., Cardinali-Benigni, M., Lauwers, H. M., Jacobs, C., Stevaert, A., Gonçalves, S. M., Cunha, C., Debaveye, Y., Hermans, G., Heylen, J., Humblet-Baron, S., Lagrou, K., Maessen, L., Meersseman, P., Peetermans, M., Redondo-Rios, A., Seldeslachts, L., Starick, M. R., Thevissen, K., … Carvalho, A. (2024). Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis. American Journal of Respiratory and Critical Care Medicine, 210(10), 1230–1242. https://doi.org/10.1164/rccm.202401-0145ocpor
dc.identifier.doi10.1164/rccm.202401-0145OCpor
dc.identifier.eissn1535-4970por
dc.identifier.issn1073-449Xpor
dc.identifier.pmid38865563
dc.identifier.urihttps://hdl.handle.net/1822/96543
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherAmerican Thoracic Societypor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50026%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50026%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FMED-OUT%2F1112%2F2021/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/CEEC IND 2018/CEECIND%2F04058%2F2018%2FCP1581%2FCT0015/PTpor
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/847507/EUpor
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/724173/EUpor
dc.relation2022.06674.PTDCpor
dc.relationinfo:eu-repo/grantAgreement/FCT/CEEC IND 2018/CEECIND%2F04058%2F2018%2FCP1581%2FCT0015/PTpor
dc.relation.publisherversionhttps://www.atsjournals.org/doi/10.1164/rccm.202401-0145OCpor
dc.rightsopenAccesspor
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/por
dc.subjectHumanspor
dc.subjectRetrospective Studiespor
dc.subjectSARS-CoV-2por
dc.subjectBronchoalveolar Lavage Fluidpor
dc.subjectRNA, Ribosomal, 16Spor
dc.subjectMicrobiotapor
dc.subjectPulmonary Aspergillosispor
dc.subjectCoinfectionpor
dc.subjectCOVID-19por
dc.subjectInfluenza, Humanpor
dc.subjectLungpor
dc.subjectaspergillosispor
dc.subjectimmunologypor
dc.subjectinfluenzapor
dc.subjectmicrobiomepor
dc.subject.fosCiências Médicas::Ciências da Saúdepor
dc.subject.odsSaúde de qualidadepor
dc.titleProfiling bacteria in the lungs of patients with severe influenza versus COVID-19 with or without Aspergillosispor
dc.typearticleeng
dspace.entity.typePublicationen
oaire.citationEndPage1242por
oaire.citationIssue10por
oaire.citationStartPage1230por
oaire.citationVolume210por
oaire.versionVoRpor
sdum.journalAmerican Journal of Respiratory and Critical Care Medicinepor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
feys-et-al-2024-profiling-bacteria-in-the-lungs-of-patients-with-severe-influenza-versus-covid-19-with-or-without.pdf
Tamanho:
1.35 MB
Formato:
Adobe Portable Document Format
Descrição: